Cancer Survival Analysis in Germany - Heading Towards Representative and Comparable Findings

被引：14

作者：

Nennecke, A. ^{[1
]}

Brenner, H. ^{[2
]}

Eberle, A. ^{[3
]}

Geiss, K. ^{[4
]}

Holleczek, B. ^{[5
]}

Kieschke, J. ^{[6
]}

Kraywinkel, K. ^{[7
]}

机构：

[1] Gesundheit & Verbraucherschutz, Hamburg Krebsregister Behorde Soziales Familie, Hamburg, Germany

[2] Deutsch Krebsforschungszent, Abt Klin Epidemiol & Alternsforsch, Heidelberg, Germany

[3] Bremer Inst Pravent Forsch & Sozialmed, Bremer Krebsregister, Bremen, Germany

[4] Bevolkerungsbezogenes Krebsregister Bayern, Erlangen, Germany

[5] Krebsregister Saarland, Saarbrucken, Germany

[6] Epidemiol Krebsregister Niedersachsen, Oldenburg, Germany

[7] Dachdokumentat Krebs Robert Koch Inst, Epidemiol Krebsregister Nordrhein Westfalen Munst, Berlin, Germany

来源：

GESUNDHEITSWESEN | 2010年 / 72卷 / 10期

关键词：

cancer registry; survival analysis; methods; data quality; LONG-TERM SURVIVAL; PERIOD ANALYSIS; INCOMPLETE REGISTRATION; EMPIRICAL-EVALUATION; DEATH CERTIFICATE; COLORECTAL-CANCER; POPULATION; TRENDS; PROGNOSIS; PROGRESS;

D O I：

10.1055/s-0029-1242772

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Cancer is an important issue within the German health care system with an estimated annual number of 435 000 incident cases and almost 210 000 deaths. Data of population-based cancer registries enable us to identify improvements of survival in oncological patients due to progress in therapeutic care and secondary prevention, as well as to investigate regional and international differences of this outcome. Comparing cancer survival rates, however, requires considering the impact of both methodical approaches and data quality. Potential factors of influence like algorithms, reference population, completeness of case ascertainment and quality of follow-up are discussed. For the first time harmonized proceedings are recommended in order to achieve comparability of population-based cancer survival rates in Germany.

引用

页码：692 / 699

页数：8

共 53 条

[1]

Altman DG, 1998, BRIT MED J, V317, P468

[2]

[Anonymous], BUNDESGESUNDHEITSBL

[3]

[Anonymous], 1995, IARC SCI PUBLICATION

[4]

[Anonymous], KREBS DEUTSCHL 2003

[5] The EUROCARE Study: strengths, limitations and perspectives of population-based, comparative survival studies [J].

Berrino, F. .

ANNALS OF ONCOLOGY, 2003, 14 :V9-V13

[6] Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study [J].

Berrino, Franco ;

De Angelis, Roberta ;

Sant, Milena ;

Rosso, Stefano ;

Lasota, Magdalena B. ;

Coebergh, Jan W. ;

Santaquilani, Mariano .

LANCET ONCOLOGY, 2007, 8 (09) :773-783

[7]

Bollmann A, 2004, STRAHLENTHER ONKOL, V180, P488, DOI 10.1007/s00066-004-1184-7

[8] Long-term survival of cancer patients in Germany achieved by the beginning of the third millenium [J].

Brenner, H ;

Stegmaier, C ;

Ziegler, H .

ANNALS OF ONCOLOGY, 2005, 16 (06) :981-986

[9] Population-based monitoring of cancer patient survival in situations with imperfect completeness of cancer registration [J].

Brenner, H ;

Hakulinen, T .

BRITISH JOURNAL OF CANCER, 2005, 92 (03) :576-579

[10] Use of period analysis for providing more up-to-date estimates of long-term survival rates:: empirical evaluation among 370 000 cancer patients in Finland [J].

Brenner, H ;

Söderman, B ;

Hakulinen, T .

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2002, 31 (02) :456-462

← 1 2 3 4 5 6 →